Skip to content

600030.SH

CITIC Securities Co., Ltd.

SSE · Financial Services · Financial - Capital Markets · CN

CNY 24.69
−1.44%
Ask drillr
  • Oct 6, 2026, 08:57 UTC

    More than 10 Chinese securities firms have connected their AI capabilities to third-party AI platforms including Kimi, WorkBuddy, Qwen and Volcano Engine, with several large brokers integrating multiple platforms at once.

  • Sep 28, 2026, 13:48 UTC

    CITIC Securities elected Zou Yingguang as its new chairman, legal representative and nomination committee member, effective September 28, 2026.

  • Sep 28, 2026, 00:11 UTC

    Alibaba showcased a one-stop AI solution at the 2026 Yunqi Conference, unveiling T-Head's Zhenwu V900 chip and Panjiu AL64/AL144 super nodes, and upgrading Alibaba Cloud to 'Agentic Cloud' with AgentCore runtime.

  • Sep 23, 2026, 02:50 UTC

    CITIC Securities announced internally on September 22 that President Zou Yingguang was appointed Party Secretary, succeeding Zhang Youjun, who will retire after more than 10 years leading the firm.

  • Sep 22, 2026, 03:56 UTC

    Cornerstone investors including Primavera Capital, GBAHIL, Orient Asset Management, Huafeng International, GF Fund, E Fund, Mirae Asset Securities Hong Kong, CSC OTC Swap, Qianhai International Fund Management, Gaoteng International Asset Management, GigaDevice, Amlogic Hong Kong, Mingshan Capital and Barings subscribed to Nazhen Technology's Hong Kong IPO.

  • Sep 21, 2026, 09:31 UTC

    The Securities Association of China held its Q3 2026 chief economist regular meeting in Beijing, where Chen Li of Chuancai Securities released the Q4 2026 chief economist economic forecast survey results and Wang Han of Industrial Securities presented an outlook on Q4 2026 macroeconomy and capital markets.

  • Sep 21, 2026, 06:45 UTC

    New China Life Insurance, CITIC Jinshi Investment and two Jinshi partnerships jointly established Jinshi (Hubei) Technology Innovation Industry Investment Fund Partnership in Hubei with RMB 2 billion in capital, with CITIC Jinshi Investment as the general partner.

  • Sep 19, 2026, 06:50 UTC

    Huawei held its Connect Conference on September 17-18, 2026, unveiling new AIDC energy and thermal management products including Taishan UPS, Hengshan centralized DC UPS, Power Module 5.0, Smart Lithium Battery 5.0 and an AI intelligent liquid cooling system.

  • Sep 18, 2026, 14:26 UTC

    Zhejiang Jingxin Pharmaceutical filed an application for listing with the Hong Kong Stock Exchange, with CITIC Securities as sole sponsor.

  • Sep 17, 2026, 23:55 UTC

    CITIC Securities saw a net margin repayment of 47.3305 million yuan on September 17, 2026, with its margin financing balance at 18.32 billion yuan, or 5.75% of its free-float market capitalization.

  • Sep 17, 2026, 13:59 UTC

    The Federal Reserve began raising interest rates, ending its easing cycle, according to a CITIC Securities research report.

  • Sep 16, 2026, 10:45 UTC

    Sichuan Biokin Pharmaceutical reported H1 2026 revenue of 187 million yuan, up 9.43% year on year, a net loss of 1.637 billion yuan, and R&D investment of 1.483 billion yuan.

  • Sep 16, 2026, 01:53 UTC

    Jinjing Technology completed a 300 million yuan Series B funding round led by existing shareholder Kangyu Capital and Fujiang Capital, with participation from Transfar Group, CITIC Jinshi and Xiang Guanglong.

  • Sep 16, 2026, 01:30 UTC

    Aike Micro Technology (Shanghai) Co., Ltd. completed its pre-IPO tutoring and moved to the tutoring acceptance stage for its planned initial public offering, with CITIC Securities as the tutoring institution.

  • Sep 16, 2026, 01:15 UTC

    Zhejiang Xingxing Cold Chain Integration Co., Ltd. filed IPO coaching registration with the Zhejiang Securities Regulatory Bureau on 2026-09-15, with CITIC Securities as coaching broker, restarting its plan for an initial public offering and listing.

  • Sep 15, 2026, 23:27 UTC

    A-share IPO underwriting volume in 2026 has already surpassed the full-year 2025 total, with CICC leading by underwriting amount, CITIC Securities ranking notably higher than mid-year, and Guotai Haitong leading by number of deals.

  • Sep 15, 2026, 19:33 UTC

    Pulike Pharmaceutical (Jiangsu) Co., Ltd. again submitted a listing application to the Hong Kong Stock Exchange, applying for a main board listing under the 18A biotech company rules, with CITIC Securities as sole sponsor.

    Source:
  • Sep 15, 2026, 10:54 UTC

    Hengbo Co., Ltd. reported that its revenue for the first half of 2026 rose 61.16% year over year while net profit attributable to shareholders fell 28.01%.

  • Sep 15, 2026, 02:42 UTC

    China's National Healthcare Security Administration held a symposium in Beijing on the pilot pre-approval system for medical service pricing items, with about 70 participants from hospitals, companies, investment institutions and media.

  • Sep 15, 2026, 00:03 UTC

    China's July nationwide electricity consumption growth slowed to 1.7% year-on-year, with residential electricity use down 5.1%, while thermal power utilization hours fell 8.5% year-on-year.

  • Sep 14, 2026, 13:54 UTC

    Datang International Power Generation replied to the Shanghai Stock Exchange's review inquiry letter regarding its planned private placement of up to RMB 8 billion in shares to specific investors.

    Source:
  • Sep 14, 2026, 11:52 UTC

    On September 14, Chinese A-share and Hong Kong innovative-drug sector ETFs rose, with Hong Kong innovative-drug-related ETFs such as Harvest Hong Kong Stock Connect Innovative Drug ETF and Southern Hang Seng Biotech ETF gaining over 4%.

  • Sep 13, 2026, 01:50 UTC

    CITIC Securities is about to undergo a board reshuffle that will also determine its top two leadership positions, following a delay of nearly nine months.

  • Aug 28, 2026, 14:39 UTC

    Betta Pharmaceuticals Co., Ltd. submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor.